Isolagen, Inc

(AMEX:ILE)

0.460

+0.010 (2.22%)

Jan 07 - Close

Open
0.550
High
0.550
Low
0.430
Vol.
159.20K
Mkt Cap
16.94M
52Wk High
2.76
52Wk Low
0.15
Avg. Vol.
186.70K
P/E (Trailing)
-0.64
Beta
0.00
Short %
5.30%
Div. Yield

After-Hours 0.46 0.00 (0.00%) Wed, 7 Jan 2009 7:40 PM

Company Profile

Isolagen, Inc

405 Eagleview Boulevard

Exton, PA 19341

United States - Map

Phone: (484) 713-6000

Fax: (484) 713-6001

Website: www.isolagen.com

State of incorporation: Delaware

CEO: Declan Daly

Employees: 42

Sector: Healthcare

Industry Group: Drugs

Industry: Drugs - Generic

Engage in autologus cellular system

An aesthetic and therapeutic company, which focuses on developing novel skin and tissue rejuvenation products.

Members owning ILE also own

AIG (100.00%), FIS (100.00%), FNM (100.00%), FRE (100.00%), T (100.00%)

Member sentiment (?)    Neutral

Top members owning ILE

* Average monthly return vs. S&P 500

Recent opinions on ILE

No recent Opinions for ILE